Esophageal Cancer
Copyright ©The Author(s) 2004. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Aug 1, 2004; 10(15): 2168-2173
Published online Aug 1, 2004. doi: 10.3748/wjg.v10.i15.2168
Expression of cyclooxygenase-2 in human esophageal squamous cell carcinomas
Jian-Gang Jiang, Jiang-Bo Tang, Chun-Lian Chen, Bao-Xing Liu, Xiang-Ning Fu, Zhi-Hui Zhu, Wei Qu, Katherine Cianflone, Michael P. Waalkes, Dao-Wen Wang
Jian-Gang Jiang, Jiang-Bo Tang, Chun-Lian Chen, Bao-Xing Liu, Xiang-Ning Fu, Zhi-Hui Zhu, Dao-Wen Wang, Internal Medicine Department and Gene Therapy Center, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China
Wei Qu, Michael P. Waalkes, Inorganic Carcinogenesis Section, Laboratory of Comparative Carcinogenesis, National Cancer Institute at the National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA
Katherine Cianflone, Mike Rosenbloom Laboratory for Cardiovascular Research, McGill University Health Center, Montreal, Quebec H3A 1A1, Canada
Author contributions: All authors contributed equally to the work.
Correspondence to: Dr. Dao-Wen Wang, Department of Internal Medicine and Gene Therapy Center, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China. dwwang@tjh.tjmu.edu.cn
Telephone: +86-27-83662842 Fax: +86-27-83662842
Received: November 17, 2003
Revised: November 23, 2003
Accepted: January 8, 2004
Published online: August 1, 2004
Abstract

AIM: To determine whether cyclooxygenase-2 (COX-2) was expressed in human esophageal squamous cell carcinoma.

METHODS: Quantitative reverse transcription-polymerase chain reaction (RT-PCR), western blotting, immunohistoc-hemistry and immunofluorescence were used to assess the expression level of COX-2 in esophageal tissue.

RESULTS: COX-2 mRNA levels were increased by > 80-fold in esophageal squamous cell carcinoma when compared to adjacent noncancerous tissue. COX-2 protein was present in 21 of 30 cases of esophageal squamous cell carcinoma tissues, but was undetectable in noncancerous tissue. Immunohistochemistry was performed to directly show expression of COX-2 in tumor tissue.

CONCLUSION: These results suggest that COX-2 may be an important factor for esophageal cancer and inhibition of COX-2 may be helpful for prevention and possibly treatment of this cancer.

Keywords: $[Keywords]